FINWIRES · TerminalLIVE
FINWIRES

ASX:MVF

8 stories mentioning ASX:MVF

Every FINWIRES story that references ASX:MVF, newest first.

Asia

Australian Shares Rally; Magellan Financial Gets ACCC Approval for Barrenjoey Merger, Plans Group Rebranding

Australian shares rallied on Friday, following stocks on Wall Street higher, as investors reacted to rising hopes of a peace agreement to end the conflict in the Middle East.The S&P/ASX 200 Index jumped 1.98%, or 170.80 points, to close at 8,804.US President Donald Trump said the US had cancelled planned strikes against Iran, and that the US and Iran could sign a peace agreement as soon as ​this weekend. He said negotiations with Tehran had advanced to the highest ⁠levels of Iran's leadership. Brent oil futures fell to around $88 per barrel.Overnight, the S&P 500 rose 1.8%, the Dow Jones Industrial Average gained nearly 1.9%, and the Nasdaq Composite rose 2.5%.On the domestic front, the number of seasonally adjusted filled jobs in Australia was unchanged from initial data, according to a report released by the Australian Bureau of Statistics. Filled jobs rose 0.6% to 16.2 million in the March quarter, following a 0.3% increase in the December 2025 quarter. Total jobs rose 0.7% to 16.5 million, while job vacancies were up 5.2% to 344,000.In company news, Magellan Financial Group (ASX:MFG) said the Australian Competition and Consumer Commission approved the company's merger with Barrenjoey Capital Partners. Magellan expects to complete the merger in early July, and it plans to seek shareholder approval at an Oct. 22 meeting to change its name to Barrenjoey Group.Monash IVF Group (ASX:MVF) now expects fiscal year 2026 underlying net profit after tax of AU$17 million to AU$18 million. It earlier guided for a full fiscal year underlying net profit after tax of AU$20 million. The outlook cut is driven by lower-than-expected activity in the Australian assisted reproductive technology market in the fiscal second half.Lastly, ANZ Group Holdings (ASX:ANZ, NZE:ANZ) said that ANZ Bank New Zealand Chief Executive and ANZ Bank group executive Antonia Watson will retire, effective Sept. 30. ANZ Bank New Zealand Chief Risk Officer Ben Kelleher was named as her successor, subject to Reserve Bank of New Zealand non-objection and other regulatory engagement.

ASX 200ASX:ANZASX:MFGASX:MVFNZE:ANZ
Asia

Monash IVF Group Still Expected to Lose Australian Market Share in Fiscal 2026, Jefferies Says

Monash IVF Group (ASX:MVF) is facing tough conditions and is still forecast to lose 250 basis points of Australian market share in fiscal 2026 to end the period with a 20% share, Jefferies said in a Friday note.The company cut its fiscal 2026 underlying net profit after tax guidance to between AU$17 million and AU$18 million from AU$20 million in a move that partly reflects "the somewhat discretionary nature" of in vitro fertilization (IVF), the equity research firm said.Jefferies now expects Australian IVF market volume to shrink 3.5%, compared with a previous forecast for a 1% contraction."We do not expect a sudden turnaround in IVF volumes but highlight previous corporate interest in IVF if an acquirer is willing to take a longer-term view given favorable industry dynamics," the investment firm said.Jefferies raised its estimates for Monash's fiscal 2026 fixed costs as a percentage of revenue to about 12% from 11%, and variable costs as a percentage of revenue to over 11%.It maintained a buy rating on the company but lowered its price target to AU$0.80 from AU$0.90.Monash IVF Group's shares jumped 3% in recent Friday trade.

ASX:MVF
Asia

Monash IVF Group Cuts Fiscal Year 2026 Underlying Net Profit After Tax Guidance

Monash IVF Group (ASX:MVF) now expects fiscal year 2026 underlying net profit after tax of AU$17 million to AU$18 million, according to a Friday filing with the Australian bourse.When it reported fiscal first-half results in February, the company guided for a full fiscal year underlying net profit after tax of AU$20 million.The outlook cut is driven by lower-than-expected activity in the Australian assisted reproductive technology market in the fiscal second half. Across the market, stimulated cycle volumes fell 4.7% on a rolling three-month basis to the end of April compared with a year earlier, and the impact of adverse market conditions continued into June, the company said.Monash IVF said its international operations have seen growth, with fiscal second-half volumes likely to be "materially higher" than a year earlier.

ASX:MVF
Asia

Monash IVF Group Appoints Chief Medical Officer

Monash IVF Group (ASX:MVF) appointed Fleur Cattrall as its first chief medical officer, according to a Wednesday filing with the Australian bourse.Cattrall has over 20 years of experience in reproductive medicine, per the filing.

ASX:MVF
Asia

Monash IVF Group Rejects Revised Takeover Proposal

Monash IVF Group (ASX:MVF) rejected the revised non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP, a subsidiary of Washington H. Soul Pattinson and Co. (ASX:SOL), to acquire all of the shares in the company through a scheme of arrangement at AU$0.90 apiece, according to a Monday filing with the Australian bourse.The company's board has unanimously concluded that the proposal undervalues the company and is not in the best interest of shareholders, the filing said.

ASX:MVFASX:SOL
Asia

Australian Shares Slide; Monash IVF Group Receives Sweetened Takeover Offer from Genesis, Soul Patts Consortium

Australian shares slid on Monday's close as the US moved to blockade the critical Strait of Hormuz, sending oil prices up.The S&P/ASX 200 Index declined 0.39% or 34.60 points to close at 8,926.The US Central Command said the US will begin implementing a blockade of all maritime traffic entering and leaving Iranian ports after peace talks between Iran and the US broke down over the weekend.A report from The Wall Street ​Journal said that Trump and his ​advisers were considering limited ⁠strikes on Iran. Brent crude oil futures spiked around 7% to reach $102.17 per barrel early on Monday. Gold fell 0.7% to $4,714 per ounce.In company news, Monash IVF Group (ASX:MVF) received a revised, unsolicited, conditional, and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP Holdings (ASX:SOL) to acquire all its shares by way of a scheme of arrangement at AU$0.90 per share. Its shares closed up 16%.a2 Milk (NZE:ATM, ASX:A2M) said its infant milk formula business in China is experiencing "temporary in-market product availability issues" that will likely impact the company's performance in fiscal 2026, resulting in a cut to guidance. Its shares fell 12% on market close.Lastly, EML Payments (ASX:EML) revised its fiscal-year underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) guidance to a range of AU$47 million to AU$50 million from AU$58 million to AU$60 million. Its shares plunged 34% on market close, earlier reaching an over 12-year low point.

ASX 200ASX:A2MASX:EMLASX:MVF
Asia

Monash IVF Group Receives Sweetened Takeover Offer From Genesis, Soul Patts Consortium; Shares Climb 19%

Monash IVF Group (ASX:MVF) received a revised, unsolicited, conditional, and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP Holdings (ASX:SOL) to acquire all its shares by way of a scheme of arrangement at AU$0.90 per share, according to a Monday Australian bourse filing.The consortium, which currently owns a 19.6% stake in Monash IVF, previously made an indicative proposal at AU$0.80 per share.The company said the consortium described the offer price as the highest amount it is prepared to offer in the absence of a competing proposal, with the proposal valid until the close of business on April 21.The proposal is subject to several conditions, including exclusive due diligence with no fiduciary exceptions, negotiation and execution of transaction documentation on customary terms, unanimous board recommendation, and final internal approval from consortium members.The Monash IVF board is assessing the proposal with the assistance of financial adviser Macquarie Capital and legal adviser Clayton Utz, the filing added.Monash IVF Group's shares surged 19% in recent Monday trade, while WHSP Holdings' shares shed 1%.

ASX:MVFASX:SOL
Asia

ASX Preview: Australian Shares Set to Open Lower as US Announces Iran Blockade; Monash IVF Receives Revised Takeover Proposal

Australian shares are set to open lower on Monday after US President Donald Trump said that the US would begin a blockade of the Strait of Hormuz after peace talks between Iran and the US ended without a resolution to the conflict, sending oil prices higher.A report from The Wall Street ​Journal said that Trump and his ​advisers were considering limited ⁠strikes on Iran. Brent crude oil futures soared nearly 8% to a four-week high of $US102.80 per barrel early on Monday. Gold fell almost 2%.In corporate news, Monash IVF Group (ASX:MVF) received a revised, unsolicited, conditional, and non-binding indicative proposal from a consortium comprising Genesis Capital Investment Management and WHSP Holdings (ASX:SOL) to acquire 100% of the shares in Monash IVF via a scheme of arrangement at $0.90 per share.Pro Medicus' (ASX: PME) wholly-owned US unit, Visage Imaging, signed a AU$37 million, five-year contract renewal with Northwestern Medicine.Australia's benchmark index closed just 0.1% lower, or 12.6 points, at 8,960.60 on April 10.

ASX 200ASX:MVFASX:PMEASX:SOL